about
Emerging molecular classifications and therapeutic implications for gastric cancerPrognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysisEpstein-Barr virus and the origin of Hodgkin lymphomaDiagnostic imaging of benign and malignant neck masses in children-a pictorial review.FAMLF is a target of miR-181b in Burkitt lymphoma.Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRCNew risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt LymphomaStatus of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.Epstein-Barr virus at 50-future perspectives.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?Viral Oncology: Molecular Biology and Pathogenesis.Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.EBV based cancer prevention and therapy in nasopharyngeal carcinoma.Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma.Epstein-Barr virus-associated lymphomas
P2860
Q26745525-A0C84A80-4252-4E76-BB75-09B140C82703Q26779692-98B5AD30-DC6C-4650-90C2-529B8CF8E059Q26998999-F3F9BCEA-9E85-49AC-96FE-47C85010948DQ28074158-86F050B8-3D29-4E08-8B80-C625662BB84CQ33718130-1273A9AC-1611-42AD-AB4A-7144EAA1712BQ36344057-BDB51CC0-D1A6-4A0E-AF3C-4B27B565CFCAQ36561585-6C7F7C0C-F846-4427-9CEF-C950FC6181ABQ37254890-E6F9DE96-85E6-4F85-8086-26173872819FQ37330822-1F61FECE-2F7A-4663-A340-D8EA017B8EC5Q37336248-846B7C42-4CD1-466E-ADD4-7A531B53F935Q37736423-14F25E88-B6E5-4E42-A536-A35AAB5E2088Q38822694-F97933AA-B898-413E-825D-BF4BE639B7F4Q41921755-732FC48B-35A1-42F4-AA27-B8EBB4FBCBA8Q41928227-55FC47A4-0B9A-4D5E-86FC-6067C4EDEB91Q42261435-D5DCF211-A175-406C-859B-BB9455185923Q43035017-B34AF461-F4A5-466C-86C7-2FB193473297Q47117102-342D1703-6FD5-4E90-95ED-10C6E73EB3F6Q47571734-C09864B1-96A5-4A8E-B295-C785E2303A12Q50352275-141475C4-8065-4AB3-90E7-2C0B44A48072Q55003883-344C6159-74C4-40B9-A326-8B9A5073CF4EQ55294799-6A0CB2DD-2A91-407F-8556-284FFF875FEFQ56930876-E5A4DECE-BA7F-4C35-A697-1DA360476E84
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Epstein-Barr virus and Burkitt lymphoma.
@en
type
label
Epstein-Barr virus and Burkitt lymphoma.
@en
prefLabel
Epstein-Barr virus and Burkitt lymphoma.
@en
P2860
P921
P356
P1476
Epstein-Barr virus and Burkitt lymphoma
@en
P2093
Martin Rowe
P2860
P304
P356
10.5732/CJC.014.10190
P5008
P577
2014-11-21T00:00:00Z